As part of our practice to submit unusual and unclassified neoplasms for molecular testing, we sent this case in the setting of initial assessment to our molecular laboratory where the NGS RNA panel revealed the YAP1-NUTM1 gene fusion. This evidence concerns the gene NUTM1 and neoplasm.